Get the Stockscreener App
5.95
2.94%
-0.18
After Hours:
6.00
0.05
+0.84%
Tempest Therapeutics Inc Stock (TPST) Forecast
The Tempest Therapeutics Inc (TPST) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.7495, representing a -20.18% decrease from the current price of $5.95. The highest analyst price target is $4.7525, and the lowest is $4.7465.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TPST Price Target
Average 3.9847
(-33.03% Downside)
Is Tempest Therapeutics Inc (TPST) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.04 | Neutral |
| STOCH(9,6) | 12.03 | Buy |
| STOCHRSI(14) | 3.3661 | Buy |
| MACD(12,26) | -0.4118 | Buy |
| ADX(14) | 27.38 | Sell |
| William %R | -97.16 | Buy |
| CCI(14) | -110.46 | Sell |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.3585
Sell
|
6.3007
Sell
|
| MA20 |
6.5282
Sell
|
6.5771
Sell
|
| MA50 |
7.589
Sell
|
7.5882
Sell
|
| MA100 |
9.5289
Sell
|
9.3822
Sell
|
| MA200 |
11.99
Sell
|
15.32
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TPST could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on TPST, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.04 indicates that TPST is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.03 indicates that TPST is oversold. This indicates that TPST price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.3661 indicates that TPST is oversold. This suggests that TPST price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.38 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -110.46 indicates that TPST is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term TPST price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tempest Therapeutics Inc financial reports and earnings history, Tempest Therapeutics Inc (TPST) stock could reach $4.011 by 2030, $44.24 by 2040 and $72.59 by 2050. See the projected annual prices until 2050 of the Tempest Therapeutics Inc stock below:
- Tempest Therapeutics Inc (TPST) is expected to reach an average price of $25.30 in 2035, with a high prediction of $25.49 and a low estimate of $25.18. This indicates an $325.13% rise from the last recorded price of $5.95.
- Tempest Therapeutics Inc (TPST) stock is projected to chart a bullish course in 2040, with an average price target of $44.78, representing an $652.61% surge from its current level. The forecast ranges from a conservative $9.9682 to a sky-high $44.24.
- Our analysts predict Tempest Therapeutics Inc (TPST) to jump 525.73% by 2045, soaring from $37.47 to an average price of $37.23, potentially reaching $37.74. While $37.47 is the low estimate, the potential upside is significant.
- Tempest Therapeutics Inc (TPST) stock is expected to climb by 2050, reaching an average of $72.27, a $1,115% jump from its current level. However, a wide range of estimates exists, with high and low targets of $72.59 and $72.27, respectively, highlighting the market's uncertainty.
Tempest Therapeutics Inc Stock (TPST) Year by Year Forecast
Tempest Therapeutics Inc Stock (TPST) Price Forecast for 2025
Tempest Therapeutics Inc Stock (TPST) is expected to reach an average price of $4.801 in 2025, with a high prediction of $5.2964 and a low estimate of $4.3055. This indicates an -19.31% fall from the last recorded price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $4.7806 | $4.7465 | $4.7525 | -19.65% |
| August, 2025 | $5.0188 | $4.6447 | $4.8788 | -15.65% |
| September, 2025 | $4.6369 | $4.8761 | $4.9279 | -22.07% |
| October, 2025 | $4.6821 | $4.641 | $4.6751 | -21.31% |
| November, 2025 | $4.8403 | $4.7562 | $4.6092 | -18.65% |
| December, 2025 | $4.0155 | $4.3055 | $4.8144 | -32.51% |
Tempest Therapeutics Inc Stock (TPST) Price Forecast for 2026
The predicted value for Tempest Therapeutics Inc (TPST) in 2026 is set at an average of $2.917. Estimates vary from a peak of $5.6317 to a trough of $0.2024, indicating an -50.97% surge from the present price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.9637 | $3.9896 | $3.8326 | -33.38% |
| February, 2026 | $4.0118 | $4.0707 | $3.8918 | -32.57% |
| March, 2026 | $3.15 | $4.10 | $4.0836 | -47.06% |
| April, 2026 | $3.2052 | $3.0415 | $2.8552 | -46.13% |
| May, 2026 | $3.5534 | $3.2923 | $3.1387 | -40.28% |
| June, 2026 | $3.7115 | $3.6204 | $3.4615 | -37.62% |
| July, 2026 | $3.6969 | $3.7256 | $3.6367 | -37.87% |
| August, 2026 | $3.8949 | $3.6838 | $3.8449 | -34.54% |
| September, 2026 | $3.8233 | $3.866 | $3.8365 | -35.74% |
| October, 2026 | $0.4983 | $3.8872 | $5.6317 | -91.63% |
| November, 2026 | $0.2864 | $0.2024 | $4.9047 | -95.19% |
| December, 2026 | $0.3216 | $0.4216 | $0.5924 | -94.59% |
Tempest Therapeutics Inc Stock (TPST) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tempest Therapeutics Inc (TPST) is $6.4317, with a high forecast of $12.86 and a low forecast of $0.00723. This indicates an +8.10% increase from the last price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.8202 | $0.00723 | $1.3402 | -86.22% |
| February, 2027 | $0.322 | $0.172 | $1.2732 | -94.59% |
| March, 2027 | $0.7068 | $0.095 | $1.1908 | -88.12% |
| April, 2027 | $0.6187 | $0.0343 | $0.9198 | -89.60% |
| May, 2027 | $0.7405 | $0.4716 | $3.1075 | -87.55% |
| June, 2027 | $6.06 | $0.2546 | $5.525 | +1.85% |
| July, 2027 | $4.1263 | $4.7663 | $4.8341 | -30.65% |
| August, 2027 | $4.3627 | $4.8963 | $3.7304 | -26.68% |
| September, 2027 | $6.3231 | $4.2941 | $5.7931 | +6.27% |
| October, 2027 | $8.2993 | $6.8212 | $7.4944 | +39.48% |
| November, 2027 | $10.87 | $8.3134 | $9.8057 | +82.62% |
| December, 2027 | $13.48 | $11.97 | $12.86 | +126.49% |
Tempest Therapeutics Inc Stock (TPST) Price Forecast for 2028
In 2028, Tempest Therapeutics Inc (TPST) is projected to reach an average price of $12.31, with a high projection of $13.47 and a low estimate of $11.14. This indicates an +106.84% rise from the last price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.53 | $13.24 | $12.98 | +127.44% |
| February, 2028 | $13.59 | $13.39 | $13.14 | +128.38% |
| March, 2028 | $12.81 | $12.79 | $13.47 | +115.28% |
| April, 2028 | $12.06 | $12.59 | $12.41 | +102.61% |
| May, 2028 | $12.36 | $12.41 | $12.30 | +107.66% |
| June, 2028 | $12.48 | $12.51 | $12.28 | +109.79% |
| July, 2028 | $12.06 | $12.18 | $12.44 | +102.67% |
| August, 2028 | $11.58 | $12.01 | $12.08 | +94.59% |
| September, 2028 | $11.12 | $11.61 | $11.63 | +86.81% |
| October, 2028 | $11.73 | $11.49 | $11.64 | +97.17% |
| November, 2028 | $11.07 | $11.14 | $11.60 | +86.08% |
| December, 2028 | $11.06 | $11.14 | $11.09 | +85.89% |
Tempest Therapeutics Inc Stock (TPST) Price Forecast for 2029
The 2029 price forecast for Tempest Therapeutics Inc Stock (TPST) is $7.6322 on average, with a high prediction of $10.93 and a low estimate of $4.3356. This represents an +28.27% increase from the previous price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.08 | $11.03 | $10.93 | +86.20% |
| February, 2029 | $9.8451 | $9.9978 | $10.69 | +65.46% |
| March, 2029 | $9.7714 | $9.8414 | $9.7092 | +64.23% |
| April, 2029 | $9.9478 | $9.7837 | $9.54 | +67.19% |
| May, 2029 | $7.8182 | $8.4256 | $9.5965 | +31.40% |
| June, 2029 | $8.3245 | $8.5024 | $8.194 | +39.91% |
| July, 2029 | $8.6308 | $8.4786 | $8.4608 | +45.06% |
| August, 2029 | $8.4712 | $8.5512 | $8.4672 | +42.37% |
| September, 2029 | $8.3376 | $8.3376 | $8.3753 | +40.13% |
| October, 2029 | $8.34 | $8.3317 | $8.3698 | +40.17% |
| November, 2029 | $8.1473 | $8.1543 | $8.2326 | +36.93% |
| December, 2029 | $3.5306 | $4.3356 | $8.0584 | -40.66% |
Tempest Therapeutics Inc Stock (TPST) Price Forecast for 2030
Tempest Therapeutics Inc Stock (TPST) is expected to reach an average price of $9.3277 in 2030, with a high forecast of $16.72 and a low forecast of $1.9352. This signifies an +56.77% surge from the last price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.301 | $4.2547 | $4.011 | -27.71% |
| February, 2030 | $4.2174 | $4.1733 | $3.8733 | -29.12% |
| March, 2030 | $2.8637 | $3.1737 | $3.1715 | -51.87% |
| April, 2030 | $2.94 | $2.9928 | $2.83 | -50.59% |
| May, 2030 | $2.5904 | $2.6904 | $2.4564 | -56.46% |
| June, 2030 | $2.3168 | $2.5068 | $2.3686 | -61.06% |
| July, 2030 | $1.9872 | $2.119 | $1.9831 | -66.60% |
| August, 2030 | $15.36 | $1.9352 | $15.20 | +158.17% |
| September, 2030 | $13.78 | $14.27 | $13.79 | +131.52% |
| October, 2030 | $12.86 | $13.93 | $12.81 | +116.16% |
| November, 2030 | $15.04 | $13.50 | $14.91 | +152.70% |
| December, 2030 | $16.82 | $15.86 | $16.72 | +182.69% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):